chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chest pain, fever, N&V. Symptoms: CHEST PAIN, UNSPECIFIED(R079). Diagnosed with myopericarditis  F/U 29 Mar 2007- wtih smallpox-associated myopericarditis documetned durign recent admission. Feels fine, sx's resolved, still taking NSAIDS.  During admission, his LVEF was mildly depressed, received 1-2 days of steroids only.
No adverse event; Given vaccine which was beyond the 30 day use by date; Given vaccine which underwent temperture excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Given vaccine which underwent temperture excursion), EXPIRED PRODUCT ADMINISTERED (Given vaccine which was beyond the 30 day use by date) and NO ADVERSE EVENT (No adverse event) in a 34-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 083B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 17-Aug-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In August 2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Given vaccine which underwent temperture excursion). On 17-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Given vaccine which was beyond the 30 day use by date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Given vaccine which underwent temperture excursion), EXPIRED PRODUCT ADMINISTERED (Given vaccine which was beyond the 30 day use by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Given vaccine which underwent temperture excursion) and EXPIRED PRODUCT ADMINISTERED (Given vaccine which was beyond the 30 day use by date).    No concomitant products reported.  It was reported that the lot number underwent temperature excursion on 15 to 17 Aug 2022 and was administered to 16 patients post temperature excursion.   No treatment products reported.
"it was awful; shook like a leaf; chills; body aches; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL ("it was awful), TREMOR (shook like a leaf), CHILLS (chills) and MYALGIA (body aches) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Tested positive for Covid.) in January 2020.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced CHILLS (chills) and MYALGIA (body aches). On an unknown date, the patient experienced FEELING ABNORMAL ("it was awful) and TREMOR (shook like a leaf). At the time of the report, FEELING ABNORMAL ("it was awful), TREMOR (shook like a leaf), CHILLS (chills) and MYALGIA (body aches) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No other relevant concomitant medication were reported. No treatment information were reported.
doses administered after excursion; No adverse event; Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable 131 patients received doses of the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable 131 patients received doses of the vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event) in a 43-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7147B) for COVID-19 prophylaxis.     No Medical History information was reported.   On 18-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Oct-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable 131 patients received doses of the vaccine). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable 131 patients received doses of the vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable 131 patients received doses of the vaccine) and PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion).    No concomitant medications were reported.  Reportedly, Pharmacist called to discuss a temperature excursion that occurred several days ago in the freezer. the excursion was found out in an audit and all the vaccines were viable. No adverse reactions reported for the patient.  No treatment medications were reported.
Patient was 4 days away from turning 5 years old at time of vaccination. No adverse events were reported.
Information has been received concerning a pt was vaccinated on 06/06/00 with several vaccines and on 06/12/00 he developed a rash on his upper right thigh area with a total of 3 lesions noted. the rash was noted as chicken pox appearance with less than 20 vesicles scattered diffusely. The pt also had an injection site wheal. The pt was afebrile and sought unspecified medical attention. On 06/27/00 the pt recovered.
12/30 Vaccination. morning Moderate L deltoid pain 4:15 fatigue, HA, body aches.  7pm; 2 hours later temp 101.2, HR increase, jaw pain, HA, unable to sleep. Tylenol at 9pm 12/31/2020 same symptoms. HR still up, achy. same symptoms, fever, nausea, body aches, persistent arm pain. Bruising at site of injection.  1/1/2021 HA, body ache, fatigue, body ache; Tylenol.  1/2/2021; mild HA, mild arm pain, bruising at injection site (visible day after day of vaccination).  *HR increase lasted till 1/2/2021. Lack of sleep lasted 2 nights.  Called colleague in urgent care. COVID test; negative  *COVID + in July **2nd pregnancy. Due May 2nd  ***ABLE AND WILLING TO BE PART OF PREGNANCY VACCINATION STUDY
patient had swelling of the injected arm at first dose and was treated in er.  she was told it was a staph infection and given antibiotics.  a report was submitted at the time.  she was told by the doctor who treated the staph infection that she could get the second shingrix vaccine.  she recieved the second vaccine on 9/10/2022.  on 9/12/2022 she came into the pharmacy after leaving the er for the same rxn she had with the first vaccine to inform us what had happened and that this time they told her she was allergic to the vaccine.  they gave her a prescritpion for prednisone and sent her home.  the arm was visibly swollen but there were no other effects reported by the patient.
Approximately 10 minutes after receiving the vaccine, I felt tingling in my hands and feet. I reported it to the staff, and they consulted with each other before the nurse who gave me a shot came over and asked me more about it. She was surprised by it and said she hadn't seen that reaction before. She then googled and found it does sometimes happen. I was kept longer for observation and then went back to my office to eat and drink before getting on the road, thinking that might help. I figured it was just a temporary vaccine side effect and didn't think much about it at first, (Wondered if my reaction could have been pronounced since I had COVID in February.) But then the tingling symptoms didn't go away and came and went without a clear pattern. I have experienced them in both hands and feet; sometimes all extremities at once, sometimes just one or two -- on either side of the body or one extremity (a hand or a foot, sometimes more in the fingers, sometimes in the hand). While I may notice it more while I'm sitting, it doesn't go away when I walk. Then about a week or two after the vaccine (about a week or two ago), I started finding myself putting my hand to my lips or left side of my face because I felt slight numbness there. It started at my lips and a cm or inch spot around my left cheekbone, but more recently, it is my lips and a larger swath of my lower face. Always or almost always left side of my face. So here I am today, three weeks after the vaccine and I still (daily) feel tingly hands and/or feet and slight numbness on the left side of my face and lips. This is concerning to me and I am holding off on my 2nd vaccine until I can see a neurologist.
I had a very sore arm which is normal, however the day after I received the vaccine I was extremely nauseous and I threw up 5x at 7:30 AM. I had a migraine the rest of the day and was extremely tired, sleeping a total of 19 hours.
Fever; Constant headache; Nauseous; Cannot sleep; Cannot eat or drink anything cannot eat or drink anything only little sips of water; Very very sick; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Cannot sleep), FEEDING DISORDER (Cannot eat or drink anything cannot eat or drink anything only little sips of water), MALAISE (Very very sick), PYREXIA (Fever) and HEADACHE (Constant headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine.   On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced INSOMNIA (Cannot sleep), FEEDING DISORDER (Cannot eat or drink anything cannot eat or drink anything only little sips of water), HEADACHE (Constant headache) and NAUSEA (Nauseous). 19-Mar-2021, the patient experienced MALAISE (Very very sick). On 20-Mar-2021, the patient experienced PYREXIA (Fever). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 20-Mar-2021, PYREXIA (Fever) had resolved. At the time of the report, INSOMNIA (Cannot sleep), FEEDING DISORDER (Cannot eat or drink anything cannot eat or drink anything only little sips of water), MALAISE (Very very sick), HEADACHE (Constant headache) and NAUSEA (Nauseous) outcome was unknown.            Patient had Ice for treatment along with the treatment medication. No concomitant product was reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Non-Significant follow-up received and reporter details were added.
Within 15 mins after the vaccine, I felt weakness and weak in the knees and chills;  it didn't feel flu-like though. and within the first few hours I had "Moderna arm" - right near the injection site - big red splotch and the arm was sore. The redness in the arm lasted a good week. It was a red blotch but not itchy or swollen. I didn't feel well for a few days after the vaccine.  The symptoms came and went as far as how I felt - chills, weak, not feeling terrific for those first few days or so. A month after the second shot, I had a rash on my neck. It came and went - a little itchy and then not itchy. (This happened for a month.) And then at the same time, I felt the same original symptoms - chills and not feeling good. It lasted about three days - the chills and weakness. And then it went away. Even since, April, I get this periodically - I feel weak in the knees, I get the chills and I have to take a Tylenol or something. The middle of May, I was taking off my makeup and I felt a burning on my face (same stuff I've been using for 20 years on my face) red splotch from  top of nose and all around and on cheekbones and down the face - it was puffy, swollen, red and caused bags under my eyes and redness under my eyes- and it still is. He gave me a cortisone lotion (my dermatologist) - It's not as red as it was but if I press on it the redness comes back. I have not changed anything with make-up; lotion or food. I have photos of it that I can send of my face. It's still here  - maybe not as bright - and I'm not sure that I notice difference using the cortisone cream. It's been a good six weeks since it started on the face.
Day after: chills, fever not controlled by Tylenol and ibuprofen, body aches, lymph node area painful, painful at injection site, fatigue Ongoing (day 5 today): Severe pain in back and hips, shooting pain in lymph node areas, severe fatigue, low grade fever off and on
Patient states she has not been able to move her flu vaccine arm (left deltoid) since flu shot; decreased mobility reported 10/21/16 to pharmacy.
D68.9 COAGULOPATHY, UNSPECIFIED TYPE 11/6/2021 ACUTE RENAL FAILURE, UNSPECIFIED D68.9 COAGULOPATHY, UNSPECIFIED TYPE 11/6/2021 BPH (BENIGN PROSTATIC HYPERPLASIA)
Night of 11/04/2022 woke up several times complaining of earache. Called doctor on 11/05/2022, went in to office and was diagnosed with an ear infection. Was prescribed amoxicillin. Spiked a fever on 11/06/2022 of 101. Has one dose antibiotic left. Has recovered from ear infection.
Pfizer COVID vaccine incorrectly diluted with 0.9% normal saline in multi dose vial with preservative. Correct diluent should be 0.9% normal saline in single-dose vial without preservative. When Pfizer was called at store level, they were not able to give any information on anything other than the single-use vials that were studied. Morning of 08/03/21 spoke to agent who gave the same information. Agent was able to say that the reason Pfizer wants medical providers to use the single-use vials is so that there is no cross contamination from puncturing the vial multiple times to dilute multiple vaccine vials. The multi-dose vials that were used were only punctured once so no risk of contamination. Considering this a valid dose still since the vaccine was still diluted and administered with normal saline. No adverse events have been reported by patient.
I only experienced soreness at the injection site; had a racing pulse during the night; Earlier this am I felt body aches; somenauseated.; I woke up feeling feverish. Now I just am feeling weak and generally tired; I woke up feeling feverish. Now I just am feeling weak and generally tired; I'm also feeling mildly dizzy and weak now; generally tired; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain, pulse rapid, general body pain, nausea, fever, feelings of weakness, dizziness and tiredness. The patient was treated with ibuprofen (Advil). On an unknown date, the outcome of the injection site pain, general body pain, nausea, fever, feelings of weakness, dizziness and tiredness were unknown and the outcome of the pulse rapid was recovered/resolved.   It was unknown if the reporter considered the injection site pain, pulse rapid, general body pain, nausea, fever, feelings of weakness, dizziness and tiredness to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient received Shingrix vaccine and experienced racing pulse during the night which had subsided.  On reporting day, early in morning the patient felt body aches and took Advil and went back to bed. The patient felt mildly nauseated. The patient woke up with feeling feverish and at the day of reporting in morning felt weak and generally tired. The patient also reported soreness at the injection site.
This spontaneous report from a contactable Nurse via a Pfizer sales representative. This Nurse reported same events for two patients. This is the first of the two reports. A male patient of unspecified age and ethnicity received TRUMENBA, via an unspecified route of administration on an unspecified date single dose. The patient medical history and the patient's concomitant medications were not reported. The patient experienced low grade fever and aches both on an unspecified date with outcome of unknown. Follow-up (29JUL2016): Follow-up attempts are completed. No further information is expected.
pt recv vax & became pale & had sz activity w/eyes rolled back, upper body jerking movements;pt eased to floor & recovered;eval by MD vasovagal rxn;
Its been past 60 days after my 1st vaccine, is it too late for my 2nd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Its been past 60 days after my 1st vaccine, is it too late for my 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Its been past 60 days after my 1st vaccine, is it too late for my 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Its been past 60 days after my 1st vaccine, is it too late for my 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported. No treatment information reported. Its been past 60 days after my 1st vaccine, is it too late for my 2nd dose.
My doctor said I need the shingles shot, I have no idea if I ever had the chickenpox or not and have no one to ask if I did. I got the shingles vaccine the Pharmacy on 12/28/15. The next day it had a small pink spot then later it got bigger looked like an ink splatter. I had the pharmacy look at the spot and they said "it was normal but keep an eye on it". 12/30/2015 my arm was sore and it hurt for anything to touch that area and the area was a little warm to the touch. As time went by the area started to get bigger and red. It got sorer and I took a tape measuring and it was 3" across. Jan. 2, 2016 the spot started to get smaller but still hurt. Jan. 3, 2016 was about 1 1/2 inches across and was still pink. Jan 4, 2016 I went to the pharmacy showed them and told them they tell and that the pain was not there now but the mark is there and they said "to write this down and be sure to tell my doctor". Today is Jan. 11, 2016 and I am going to the Doctor office and the mark is still about an 1 1/2" across, there is no pain. Jan 18, 2016 still a mark the doctor said it was like a bruise.
Clinical Summary Patient is a 90 y.o. male with a history of Afib (Eliquis), CKD III, Bell's Palsy with Chronic Left Facial Droop, Overactive Bladder and BPH. He was recently admitted to hospital 4/29-4/30/22 after treatment for TIA. He presented to hospital 9/28/2022 for 3 days of viral symptoms and 1 day of weakness with fall. In ED: SCr 1.6 and SARS-CoV-2 positive. Improved with supportive care. Discharged to home w/ HHC 9/29/22.   1. COVID-19: Vaccinated with Pfizer x3. Symptoms started on Monday 9/26/22 (3 days prior to admission). SARS-CoV-2 positive on 9/28/22. CXR 9/28/22: basilar atelectasis. Baseline inflammatory labs pending. Blood cultures 9/28/22: no growth to date. As needed IV lasix for "dry lung" strategy. Patient did not require oxygen on admission and therefore did not qualify for dexamethasone or remdesivir. Ordered 5 day course of paxlovid end date 10/4/22. 2. AKI on CKD IIIa: Baseline SCr ~1.1-1.2. SCr 1.6 in ED. Likely due to above. Given 500cc bolus in ED. Improved.  3. Mechanical Fall, Weakness: No loss of consciousness, no head strike. Trauma imaging 9/28/2022: CT Head and CT C-spine non-acute. Due to COVID. PT/OT followed. 4. Afib: rate controlled on admission. CHA2DS2-VASc of 2 on Eliquis 2.5mg BID prior to admission. Adjusted eliquis due to paxlovid course.
LOOSES FEELING IN RIGHT ARM FROM ELBOW TO WRIST; This spontaneous report received from a patient concerned a 44 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 213D21A expiry: 08-SEP-2022) dose was not reported, administered on 29-DEC-2021 for prophylactic vaccination. Age at time of vaccination 44 years old. No concomitant medications were reported. On JAN-2022, the patient experienced looses feeling in right arm from elbow to wrist. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from looses feeling in right arm from elbow to wrist. This report was non-serious.; Sender's Comments: Medical assessment comments not required as per standard procedure as the case is considered non serious.
Went into A-flutter.  Hospitalized. 3 days.  On various medications to get rate down.  Now on beta blocker.
Patient was given Pfizer dose that was not diluted. The error was notice immediately, and reported to the parents. Parents were educated on signs and symptoms to watch for requiring the error. Contacted the parents no response, and left a voice message to return our call requiring any signs and symptoms the may have. We have not heard back from the parents.